{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,27]],"date-time":"2025-09-27T13:21:09Z","timestamp":1758979269176},"reference-count":0,"publisher":"American Medical Association (AMA)","issue":"6","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Arch Dermatol"],"published-print":{"date-parts":[[2011,6,20]]},"DOI":"10.1001\/archdermatol.2011.131","type":"journal-article","created":{"date-parts":[[2011,6,21]],"date-time":"2011-06-21T00:42:14Z","timestamp":1308616934000},"page":"729","source":"Crossref","is-referenced-by-count":3,"title":["Include Discussions and Review of Systems Regarding Inflammatory Bowel Disease in Patients Starting Isotretinoin Therapy"],"prefix":"10.1001","volume":"147","author":[{"given":"Eliot N.","family":"Mostow","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"10","container-title":["Archives of Dermatology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/jamanetwork.com\/journals\/jamadermatology\/fullarticle\/423903","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2016,12,17]],"date-time":"2016-12-17T03:24:58Z","timestamp":1481945098000},"score":1,"resource":{"primary":{"URL":"http:\/\/archderm.jamanetwork.com\/article.aspx?doi=10.1001\/archdermatol.2011.131"}},"subtitle":["Comment on \u201cIsotretinoin Therapy and Inflammatory Bowel Disease\u201d"],"short-title":[],"issued":{"date-parts":[[2011,6,20]]},"references-count":0,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2011,6,20]]}},"URL":"https:\/\/doi.org\/10.1001\/archdermatol.2011.131","relation":{},"ISSN":["0003-987X"],"issn-type":[{"value":"0003-987X","type":"print"}],"subject":[],"published":{"date-parts":[[2011,6,20]]}}}